|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: PPP1CA |
Gene summary for PPP1CA |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | PPP1CA | Gene ID | 5499 |
| Gene name | protein phosphatase 1 catalytic subunit alpha | |
| Gene Alias | PP-1A | |
| Cytomap | 11q13.2 | |
| Gene Type | protein-coding | GO ID | GO:0000271 | UniProtAcc | A0A140VJS9 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 5499 | PPP1CA | GSM4909282 | Human | Breast | IDC | 7.03e-40 | 7.46e-01 | -0.0288 |
| 5499 | PPP1CA | GSM4909285 | Human | Breast | IDC | 3.88e-15 | 4.79e-01 | 0.21 |
| 5499 | PPP1CA | GSM4909287 | Human | Breast | IDC | 1.13e-02 | 2.82e-01 | 0.2057 |
| 5499 | PPP1CA | GSM4909290 | Human | Breast | IDC | 6.01e-09 | 4.85e-01 | 0.2096 |
| 5499 | PPP1CA | GSM4909291 | Human | Breast | IDC | 4.12e-03 | 3.14e-01 | 0.1753 |
| 5499 | PPP1CA | GSM4909296 | Human | Breast | IDC | 3.77e-07 | 2.30e-01 | 0.1524 |
| 5499 | PPP1CA | GSM4909297 | Human | Breast | IDC | 2.42e-08 | -1.48e-01 | 0.1517 |
| 5499 | PPP1CA | GSM4909304 | Human | Breast | IDC | 1.63e-20 | 5.00e-01 | 0.1636 |
| 5499 | PPP1CA | GSM4909308 | Human | Breast | IDC | 2.57e-07 | 4.08e-01 | 0.158 |
| 5499 | PPP1CA | GSM4909309 | Human | Breast | IDC | 2.15e-06 | 2.44e-01 | 0.0483 |
| 5499 | PPP1CA | GSM4909311 | Human | Breast | IDC | 4.45e-19 | -6.46e-02 | 0.1534 |
| 5499 | PPP1CA | GSM4909312 | Human | Breast | IDC | 3.19e-15 | 4.03e-01 | 0.1552 |
| 5499 | PPP1CA | GSM4909313 | Human | Breast | IDC | 5.79e-03 | 7.62e-02 | 0.0391 |
| 5499 | PPP1CA | GSM4909317 | Human | Breast | IDC | 1.19e-11 | 4.81e-01 | 0.1355 |
| 5499 | PPP1CA | GSM4909318 | Human | Breast | IDC | 6.39e-09 | 6.11e-01 | 0.2031 |
| 5499 | PPP1CA | GSM4909319 | Human | Breast | IDC | 2.09e-33 | 6.30e-02 | 0.1563 |
| 5499 | PPP1CA | GSM4909320 | Human | Breast | IDC | 2.38e-10 | 2.28e-01 | 0.1575 |
| 5499 | PPP1CA | GSM4909321 | Human | Breast | IDC | 1.72e-14 | 2.65e-01 | 0.1559 |
| 5499 | PPP1CA | brca1 | Human | Breast | Precancer | 3.83e-26 | 5.92e-01 | -0.0338 |
| 5499 | PPP1CA | brca2 | Human | Breast | Precancer | 3.61e-08 | 3.79e-01 | -0.024 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Breast |  | IDC: Invasive ductal carcinoma |
| DCIS: Ductal carcinoma in situ | ||
| Precancer(BRCA1-mut): Precancerous lesion from BRCA1 mutation carriers | ||
| Endometrium |  | AEH: Atypical endometrial hyperplasia |
| EEC: Endometrioid Cancer | ||
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| GC |  | CAG: Chronic atrophic gastritis |
| CAG with IM: Chronic atrophic gastritis with intestinal metaplasia | ||
| CSG: Chronic superficial gastritis | ||
| GC: Gastric cancer | ||
| SIM: Severe intestinal metaplasia | ||
| WIM: Wild intestinal metaplasia | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Prostate |  | BPH: Benign Prostatic Hyperplasia |
| Skin |  | AK: Actinic keratosis |
| cSCC: Cutaneous squamous cell carcinoma | ||
| SCCIS:squamous cell carcinoma in situ | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:00060918 | Breast | Precancer | generation of precursor metabolites and energy | 94/1080 | 490/18723 | 1.54e-25 | 1.64e-22 | 94 |
| GO:00159808 | Breast | Precancer | energy derivation by oxidation of organic compounds | 70/1080 | 318/18723 | 8.33e-23 | 6.37e-20 | 70 |
| GO:20012339 | Breast | Precancer | regulation of apoptotic signaling pathway | 65/1080 | 356/18723 | 7.70e-17 | 3.17e-14 | 65 |
| GO:00064138 | Breast | Precancer | translational initiation | 30/1080 | 118/18723 | 3.23e-12 | 5.58e-10 | 30 |
| GO:00064179 | Breast | Precancer | regulation of translation | 67/1080 | 468/18723 | 4.71e-12 | 7.64e-10 | 67 |
| GO:00064466 | Breast | Precancer | regulation of translational initiation | 19/1080 | 79/18723 | 7.99e-08 | 4.60e-06 | 19 |
| GO:20012356 | Breast | Precancer | positive regulation of apoptotic signaling pathway | 24/1080 | 126/18723 | 1.98e-07 | 1.01e-05 | 24 |
| GO:00100389 | Breast | Precancer | response to metal ion | 47/1080 | 373/18723 | 3.88e-07 | 1.79e-05 | 47 |
| GO:00510989 | Breast | Precancer | regulation of binding | 44/1080 | 363/18723 | 2.59e-06 | 8.65e-05 | 44 |
| GO:00434677 | Breast | Precancer | regulation of generation of precursor metabolites and energy | 22/1080 | 130/18723 | 4.95e-06 | 1.51e-04 | 22 |
| GO:20012369 | Breast | Precancer | regulation of extrinsic apoptotic signaling pathway | 24/1080 | 151/18723 | 5.78e-06 | 1.70e-04 | 24 |
| GO:00971919 | Breast | Precancer | extrinsic apoptotic signaling pathway | 30/1080 | 219/18723 | 9.42e-06 | 2.50e-04 | 30 |
| GO:00093148 | Breast | Precancer | response to radiation | 47/1080 | 456/18723 | 8.39e-05 | 1.62e-03 | 47 |
| GO:00160527 | Breast | Precancer | carbohydrate catabolic process | 21/1080 | 154/18723 | 2.10e-04 | 3.28e-03 | 21 |
| GO:00224119 | Breast | Precancer | cellular component disassembly | 44/1080 | 443/18723 | 3.17e-04 | 4.51e-03 | 44 |
| GO:00060066 | Breast | Precancer | glucose metabolic process | 23/1080 | 196/18723 | 9.54e-04 | 1.07e-02 | 23 |
| GO:00434705 | Breast | Precancer | regulation of carbohydrate catabolic process | 10/1080 | 56/18723 | 1.23e-03 | 1.32e-02 | 10 |
| GO:00059966 | Breast | Precancer | monosaccharide metabolic process | 27/1080 | 257/18723 | 1.94e-03 | 1.88e-02 | 27 |
| GO:00511008 | Breast | Precancer | negative regulation of binding | 19/1080 | 162/18723 | 2.56e-03 | 2.32e-02 | 19 |
| GO:00193186 | Breast | Precancer | hexose metabolic process | 25/1080 | 237/18723 | 2.64e-03 | 2.36e-02 | 25 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| hsa0541512 | Stomach | GC | Diabetic cardiomyopathy | 56/708 | 203/8465 | 2.48e-16 | 1.14e-14 | 8.00e-15 | 56 |
| hsa042186 | Stomach | GC | Cellular senescence | 25/708 | 156/8465 | 1.13e-03 | 7.72e-03 | 5.43e-03 | 25 |
| hsa0541513 | Stomach | GC | Diabetic cardiomyopathy | 56/708 | 203/8465 | 2.48e-16 | 1.14e-14 | 8.00e-15 | 56 |
| hsa0421811 | Stomach | GC | Cellular senescence | 25/708 | 156/8465 | 1.13e-03 | 7.72e-03 | 5.43e-03 | 25 |
| hsa0541521 | Stomach | CAG with IM | Diabetic cardiomyopathy | 56/640 | 203/8465 | 2.41e-18 | 1.10e-16 | 7.69e-17 | 56 |
| hsa0421821 | Stomach | CAG with IM | Cellular senescence | 24/640 | 156/8465 | 6.19e-04 | 5.05e-03 | 3.54e-03 | 24 |
| hsa043906 | Stomach | CAG with IM | Hippo signaling pathway | 21/640 | 157/8465 | 7.26e-03 | 4.05e-02 | 2.84e-02 | 21 |
| hsa0541531 | Stomach | CAG with IM | Diabetic cardiomyopathy | 56/640 | 203/8465 | 2.41e-18 | 1.10e-16 | 7.69e-17 | 56 |
| hsa0421831 | Stomach | CAG with IM | Cellular senescence | 24/640 | 156/8465 | 6.19e-04 | 5.05e-03 | 3.54e-03 | 24 |
| hsa0439011 | Stomach | CAG with IM | Hippo signaling pathway | 21/640 | 157/8465 | 7.26e-03 | 4.05e-02 | 2.84e-02 | 21 |
| hsa0541541 | Stomach | CSG | Diabetic cardiomyopathy | 56/633 | 203/8465 | 1.44e-18 | 6.51e-17 | 4.68e-17 | 56 |
| hsa0421841 | Stomach | CSG | Cellular senescence | 24/633 | 156/8465 | 5.29e-04 | 4.18e-03 | 3.00e-03 | 24 |
| hsa0439021 | Stomach | CSG | Hippo signaling pathway | 21/633 | 157/8465 | 6.42e-03 | 3.62e-02 | 2.61e-02 | 21 |
| hsa0541551 | Stomach | CSG | Diabetic cardiomyopathy | 56/633 | 203/8465 | 1.44e-18 | 6.51e-17 | 4.68e-17 | 56 |
| hsa0421851 | Stomach | CSG | Cellular senescence | 24/633 | 156/8465 | 5.29e-04 | 4.18e-03 | 3.00e-03 | 24 |
| hsa0439031 | Stomach | CSG | Hippo signaling pathway | 21/633 | 157/8465 | 6.42e-03 | 3.62e-02 | 2.61e-02 | 21 |
| hsa0541510 | Stomach | SIM | Diabetic cardiomyopathy | 38/465 | 203/8465 | 1.53e-11 | 4.64e-10 | 3.72e-10 | 38 |
| hsa0541511 | Stomach | SIM | Diabetic cardiomyopathy | 38/465 | 203/8465 | 1.53e-11 | 4.64e-10 | 3.72e-10 | 38 |
| Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| PPP1CA | insertion | In_Frame_Ins | novel | c.223_224insGACCCAGAAGCTCCAAGTTAC | p.Asp75delinsGlyProArgSerSerLysLeuHis | p.D75delinsGPRSSKLH | P62136 | protein_coding | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
| PPP1CA | insertion | Frame_Shift_Ins | novel | c.221_222insCGGGAAGATCCCT | p.Asp75GlyfsTer5 | p.D75Gfs*5 | P62136 | protein_coding | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
| PPP1CA | insertion | Frame_Shift_Ins | novel | c.348_349insGGAGT | p.Leu117GlyfsTer61 | p.L117Gfs*61 | P62136 | protein_coding | TCGA-BH-A0B9-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD | ||
| PPP1CA | insertion | Frame_Shift_Ins | novel | c.347_348insTTTCTTTACTTTTTTGAGA | p.Leu117PhefsTer12 | p.L117Ffs*12 | P62136 | protein_coding | TCGA-BH-A0B9-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD | ||
| PPP1CA | deletion | Frame_Shift_Del | novel | c.620delC | p.Pro207LeufsTer56 | p.P207Lfs*56 | P62136 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | ||
| PPP1CA | SNV | Missense_Mutation | c.461N>A | p.Arg154His | p.R154H | P62136 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.966) | TCGA-AA-3950-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
| PPP1CA | SNV | Missense_Mutation | novel | c.441N>A | p.Phe147Leu | p.F147L | P62136 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.727) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
| PPP1CA | SNV | Missense_Mutation | c.848N>G | p.Tyr283Cys | p.Y283C | P62136 | protein_coding | deleterious_low_confidence(0.02) | probably_damaging(1) | TCGA-AD-6964-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | folfox | PD | |
| PPP1CA | SNV | Missense_Mutation | novel | c.379N>A | p.Glu127Lys | p.E127K | P62136 | protein_coding | deleterious_low_confidence(0.01) | benign(0.057) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
| PPP1CA | SNV | Missense_Mutation | rs774510465 | c.931N>A | p.Asp311Asn | p.D311N | P62136 | protein_coding | deleterious_low_confidence(0.05) | benign(0) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| 5499 | PPP1CA | KINASE, DRUGGABLE GENOME, PROTEIN PHOSPHATASE | CANTHARIDIN | CANTHARIDIN | ||
| 5499 | PPP1CA | KINASE, DRUGGABLE GENOME, PROTEIN PHOSPHATASE | DEMETHYL-CANTHARIDIN | DEMETHYL-CANTHARIDIN | ||
| 5499 | PPP1CA | KINASE, DRUGGABLE GENOME, PROTEIN PHOSPHATASE | DNDI1417601 | CHEMBL1503729 |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |